Director/PDMR Shareholding

RNS Number : 4651Z

Dechra Pharmaceuticals PLC

18 September 2020

 

18 September 2020

Dechra Pharmaceuticals PLC

Notification of Transactions by Persons Discharging Managerial Responsibilities

On 18 September 2020, Dechra Pharmaceuticals PLC was notified by a Director of the Company and Person Discharging Managerial Responsibilities that he had completed a transfer of part of his beneficial interest in Dechra.

Ian Page, Executive Director, has transferred 2,000 ordinary shares in the Company to his son, David Page. Following these transactions, Ian Page will continue to retain a beneficial holding of 623,374 ordinary shares which represents 0.577% of the current issued share capital in the Company.

The Notification of Dealing Form set out below is provided in accordance with Article 19.3 of MAR.

Notification of Dealing Form:

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Ian Page
2.	Reason for the notification
a)	Position/status	Director
b)	Initial notification/amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Transfer of Shares
c)	Price(s) and volumes(s)	Price(s) £N/A	Volume(s) 2,000
d)	Aggregated information -Aggregate volume - Price - Total	2,000 £N/A £N/A
e)	Date of the transaction	18 September 2020
f)	Place of the transaction	Outside a trading venue

Enquiries:
Dechra Pharmaceuticals PLC
Ian Page, Chief Executive Officer	Office:  [phone]
Paul Sandland, Acting Chief Financial Officer e-mail: [e-mail]	Office:  [phone]
TooleyStreet Communications Ltd
Fiona Tooley, Director e-mail: [e-mail]	Office:  [phone] Mobile: [phone]

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com  

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

DSHKKFBDDBKDQCD